clinical trials
Our blog features information and personal perspectives on topics of interest to the hereditary cancer community.Stay up to date on research and information
Sign Up for FORCE NewslettersSeptember 05, 2021
A Different Kind of Trial: A Litigation Attorney's Take on Being in a National Institutes of Health Clinical Trial
Posted in:
Research ,
Men With Mutations
Tags:
Hereditary Cancer ,
BRCA2 ,
Prostate Cancer ,
Clinical Trials ,
Volunteer
September 06, 2013
Challenges to Hereditary Cancer Research
Posted in:
Research
Tags:
Hereditary Cancer Research ,
Clinical Trials ,
Patient Engagement ,
Patient Centered Research
September 03, 2020
Including Men in Breast Cancer Trials (Finally!)
Posted in:
Research ,
Men With Mutations
Tags:
Breast Cancer ,
Clinical Trials ,
Male Breast Cancer ,
CHEK2 ,
Research
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
September 19, 2017
Insurance Coverage for Clinical Trial Participation: Significant Barriers Remain
Posted in:
Laws, Protections And Public Policy ,
Research
Tags:
Clinical Trials ,
Medicare ,
Insurance ,
Insurance Coverage ,
Medicaid
December 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA ,
Breast Cancer ,
Hereditary Cancer Research ,
BRCA1 ,
BRCA2 ,
FDA ,
Clinical Trials ,
PARP Inhibitor
March 21, 2014
Matching Participants to Clinical Trials
Posted in:
Research
Tags:
Clinical Trials ,
Patient Engagement ,
Research Advocacy ,
ABOUT
January 13, 2021
Honoring the Life of Teri Woodhull
Posted in:
Voices
Tags:
BRCA ,
Hereditary Cancer ,
Ovarian Cancer ,
Clinical Trials ,
FORCE
August 27, 2018
FORCE Co-Authors Paper on Engaging Patient Advocates in Research
Posted in:
Research
Tags:
Clinical Trials ,
Patient Advocacy ,
Patient Engagement ,
Cancer Research ,
Research Advocacy ,
Patient Centered Research
May 21, 2020
Clinical Trials are Essential for Improving Healthcare
Posted in:
Research ,
XRAY
Tags:
Hereditary Cancer ,
Breast Cancer ,
Ovarian Cancer ,
HBOC ,
Clinical Trials ,
Cancer Research ,
Research